Virtual Incision Gets OK From FDA for Clinical Studies on Bowel Resection Procedures
April 19, 2022
Virtual Incision announced that the FDA has granted it an Investigational Device Exemption to complete research on how its robot-assisted surgery platform can aid bowel resection procedures.
Virtual Incision Obtains Series C Funding for MIRA Robotic Surgical System
November 30, 2021
The MIRA surgical platform, which Virtual Incision says is the first miniaturized robot of its kind, is currently in clinical studies as the company gets financing for commercialization.
Virtual Incision’s MIRA Miniature Robotic System Assists in Its First Surgical Procedure at Bryan Medical Center
August 16, 2021
On its path to commercialization, Virtual Incision has participated in the first procedure using its MIRA miniature robotic surgical system under an FDA IDE exemption.